Vancomycin-resistant enterococci

被引:163
作者
Murray, BE [1 ]
机构
[1] UNIV TEXAS,SCH MED,CTR STUDY EMERGING & REEMERGING PATHOGENS,HOUSTON,TX 77030
关键词
D O I
10.1016/S0002-9343(99)80270-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Enterococci have been recognized as an important cause of nosocomial infections for almost 20 years and as a cause of endocarditis for almost a century. While long known for their capacity of displaying multiple antibiotic resistant traits, the extent to which this could occur was not fully appreciated until the emergence of enterococci with acquired resistance to vancomycin; this resistance has been particularly problematic because it often occurs in the uncommon subset of enterococci that are also highly resistant to ampicillin--a combination with devastating therapeutic consequences. The observation that vancomycin resistance can be transferred to and expressed in other gram-positive organisms, for which vancomycin is often considered the primary therapeutic alternative, is a chilling reminder of just how close we may be to a wide array of potentially untreatable ''killer'' microbes. (C) 1997 by Excerpta Medica, Inc.
引用
收藏
页码:284 / 293
页数:10
相关论文
共 37 条
[1]  
[Anonymous], 1995, MMWR Recomm Rep, V44, P1
[2]   CONTRIBUTION OF VANY D,D-CARBOXYPEPTIDASE TO GLYCOPEPTIDE RESISTANCE IN ENTEROCOCCUS-FAECALIS BY HYDROLYSIS OF PEPTIDOGLYCAN PRECURSORS [J].
ARTHUR, M ;
DEPARDIEU, F ;
SNAITH, HA ;
REYNOLDS, PE ;
COURVALIN, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (09) :1899-1903
[3]   CHARACTERIZATION OF TN1546, A TN3-RELATED TRANSPOSON CONFERRING GLYCOPEPTIDE RESISTANCE BY SYNTHESIS OF DEPSIPEPTIDE PEPTIDOGLYCAN PRECURSORS IN ENTEROCOCCUS-FAECIUM BM4147 [J].
ARTHUR, M ;
MOLINAS, C ;
DEPARDIEU, F ;
COURVALIN, P .
JOURNAL OF BACTERIOLOGY, 1993, 175 (01) :117-127
[4]   GENETICS AND MECHANISMS OF GLYCOPEPTIDE RESISTANCE IN ENTEROCOCCI [J].
ARTHUR, M ;
COURVALIN, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (08) :1563-1571
[5]   MODIFICATION OF PEPTIDOGLYCAN PRECURSORS IS A COMMON FEATURE OF THE LOW-LEVEL VANCOMYCIN-RESISTANT VANB-TYPE ENTEROCOCCUS D366 AND OF THE NATURALLY GLYCOPEPTIDE-RESISTANT SPECIES LACTOBACILLUS-CASEI, PEDIOCOCCUS-PENTOSACEUS, LEUCONOSTOC-MESENTEROIDES, AND ENTEROCOCCUS-GALLINARUM [J].
BILLOTKLEIN, D ;
GUTMANN, L ;
SABLE, S ;
GUITTET, E ;
VANHEIJENOORT, J .
JOURNAL OF BACTERIOLOGY, 1994, 176 (08) :2398-2405
[6]   EVIDENCE FOR THE GENETIC UNRELATEDNESS OF NOSOCOMIAL VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECIUM STRAINS IN A PEDIATRIC HOSPITAL [J].
BINGEN, EH ;
DENAMUR, E ;
LAMBERTZECHOVSKY, NY ;
ELION, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (09) :1888-1892
[7]   OUTBREAK OF MULTIDRUG-RESISTANT ENTEROCOCCUS-FAECIUM WITH TRANSFERABLE VANB CLASS VANCOMYCIN RESISTANCE [J].
BOYCE, JM ;
OPAL, SM ;
CHOW, JW ;
ZERVOS, MJ ;
POTTERBYNOE, G ;
SHERMAN, CB ;
ROMULO, RLC ;
FORTNA, S ;
MEDEIROS, AA .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (05) :1148-1153
[8]   COMPARISON OF DIFFERENT BETA-LACTAM-GLYCOPEPTIDE-GENTAMICIN COMBINATIONS FOR AN EXPERIMENTAL ENDOCARDITIS CAUSED BY A HIGHLY BETA-LACTAM-RESISTANT AND HIGHLY GLYCOPEPTIDE-RESISTANT ISOLATE OF ENTEROCOCCUS-FAECIUM [J].
CARON, F ;
PESTEL, M ;
KITZIS, MD ;
LEMELAND, JF ;
HUMBERT, G ;
GUTMANN, L .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (01) :106-112
[9]   CHARACTERIZATION OF GLYCOPEPTIDE-RESISTANT ENTEROCOCCI FROM UNITED-STATES HOSPITALS [J].
CLARK, NC ;
COOKSEY, RC ;
HILL, BC ;
SWENSON, JM ;
TENOVER, FC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (11) :2311-2317
[10]   VANCOMYCIN-DEPENDENT ENTEROCOCCUS-FAECIUM ISOLATED FROM STOOL FOLLOWING ORAL VANCOMYCIN THERAPY [J].
DEVER, LL ;
SMITH, SM ;
HANDWERGER, S ;
ENG, RHK .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (10) :2770-2773